BrightSpring Health Services, Inc. (BTSG)
NEUTRALFundamental
67
Precio
$56.63
Capitalización Bursátil
$11.62B
Parte 1 · Cuánto vale la empresa
Resumen
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance y Liquidez
Ingresos
$14.37B
Últimos 12 meses (hasta 30/6/2026)
Beneficio Neto
$366M
Últimos 12 meses (hasta 30/6/2026)
Flujo de Caja Libre
$395M
Patrimonio Neto Total
$1.88B
Pasivo Total
$4.53B
Ratio de Liquidez
1.59
Cobertura de Intereses
2.94
Deuda/EBITDA
5.20
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$71.31
Precio Actual
$56.63
Margen de Seguridad
+20.6%
Rango de Valor Justo
$56.87 - $85.75
Métodos de Estimación
Métricas de Valoración
Ratio P/E
36.05
ROE
10.2%
Ratio P/B
5.75
P/FCF
29.26
Margen Bruto
12.4%
ROIC
8.0%
Radar de Rentabilidad
Value Creation (Economic Moat)
ROIC
8.0%
WACC
13.2%
ROIC − WACC
-5.2 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Criterios de Análisis Fundamental
Superado (18)
- EPS shows upward trend
- Price CAGR 86.00%
- ROIC 8.0%
- P/FCF 29.26
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 19.0%
- Revenue Growth 5Y 18.3%
- Analyst Consensus 96% Buy
- Earnings Surprise avg 17.2%
- PEG Ratio 0.68
- Earnings Quality (OCF/NI) 1.38
- Net Margin Trend 2.5% vs 0.6%
- Piotroski F-Score 7/9
Fallido (8)
- Gross Margin 12.4%
- P/B Ratio 5.75
- Operating Margin 3.1%
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Share Dilution 9.2%
No disponible (1)
- Dividend Payout NaN%
Piotroski F-Score
Solidez financiera fuerte
Calidad de los Beneficios
Alta calidad: beneficios respaldados por efectivo
Dilución de Acciones
Emitiendo nuevas acciones, diluyendo la participación
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. Jon B. Rousseau | Chairman, President & CEO | 51 |
| Ms. Jennifer A. Phipps | CFO, Executive VP & Corporate Secretary | 44 |
| Ms. Lisa Nalley | Chief of Staff & Senior VP of Human Resources | 52 |
| Ms. Jennifer Yowler | Senior VP of Sales & Account Management - PharMerica | 48 |
| Mr. Scott Greenwell Pharm.D. | Executive VP & President of PharMerica | - |
| Mr. Charles H. Wardrip | Chief Information Officer | - |
Riesgo de Auditoría
7
Riesgo del Consejo
9
Riesgo de Compensación
8
Riesgo de Derechos del Accionista
8
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Latest News
Recent headlines for BTSG, sourced from Markets Gazette.
- 2/27/2026NEUTRALBrightSpring (BTSG) Earnings Call Transcript
Markets Gazette reports that BrightSpring Health Services, Inc. (BTSG) held its earnings call on February 27, 2026. However, the detailed content of the transcript is not yet publicly available. Without access to specific financial data, future guidance, or management commentary, investors lack concrete elements to assess the company's performance or outlook. The absence of information prevents a clear directional analysis, leaving the stock in a holding pattern. The market will remain in suspense until the details are published, which could then trigger significant movements once key data points are released.
via Markets Gazette